$CLCD

Secondaries announced 9.8.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: IMPAC Mortgage Symbol: IMH Price: Last trade $16.87 Trade Date: TBD Shares: 2.5 million Underwriter(s) JMP Securities Rating=Subscription Needed Company: CoLucid[…]

IPO Weekly Recap 5.1.2015 – Tough Sledding for New Issues

This past week four IPOs debuted, eleven updated terms and two new deals filed. It was tough sledding for the four deals that debuted. The strongest deal of the week, BluePrint Medicines Corporation (Nasdaq: BPMC), upsized and priced ($18.00) above range. ‘BPMC’ opened 30-percent higher with a $23.40 tick at first trade. However, BluePrint traded[…]

IPO Weekly Recap: Apigee sells off in opening day

This past week two IPOs debuted, seven updated terms and six new deals filed. The deal of the week, Apigee Corporation (Nasdaq: APIC), was many-multiple times oversubscribed and priced ($17.00) at the mid-point of the $16-$18 range. ‘APIC’ opened with a three-dollar premium with a $20.00 first trade; however, the deal sold off on day[…]

Scroll to top
error: Content is protected !!